 |
|
|
| |
Safety Profile of HIV-1 Patients Co-Infected With Hepatitis B or C in the Maraviroc Expanded Access Program
|
| |
| |
Reported by Jules Levin
EACS Nov 13 2009 Cologne Germany
A Lazzarin1, S Than2, S R Valluri2, G Mukwaya2and A Ayoub3
1San Raffaele Scientific Institute, Milan, Italy; 2Pfizer Inc, New York, NY, USA; 3Pfizer Global R&D, Sandwich, UK
For further information, please contact: Soe Than and Srinivas Rao Valluri, Pfizer Inc, New York, NY.
RESULTS
References
1. Gulick RM, et al. N Engl J Med2008;359:1429-1441.
|
| |
|
|
|
|
|
